Year |
Citation |
Score |
2017 |
Venkataraman T, Coleman C, Frieman M. Overactive EGFR Signaling Leads to Increased Fibrosis After SARS-CoV Infection. Journal of Virology. PMID 28404843 DOI: 10.1128/Jvi.00182-17 |
0.696 |
|
2017 |
Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Research. PMID 28390872 DOI: 10.1016/J.Antiviral.2017.03.022 |
0.654 |
|
2017 |
Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, Flyer DC, Frieman MB. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine. PMID 28237499 DOI: 10.1016/J.Vaccine.2017.02.012 |
0.655 |
|
2016 |
Coleman CM, Sisk JM, Halasz G, Zhong J, Beck SE, Matthews KL, Venkataraman T, Rajagopalan S, Kyratsous CA, Frieman MB. CD8+ T cells and Macrophages Regulate Pathogenesis in a Mouse Model of MERS-CoV Disease. Journal of Virology. PMID 27795435 DOI: 10.1128/Jvi.01825-16 |
0.618 |
|
2015 |
Taylor JK, Coleman CM, Postel S, Sisk JM, Bernbaum JG, Venkataraman T, Sundberg EJ, Frieman MB. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference. Journal of Virology. 89: 11820-33. PMID 26378163 DOI: 10.1128/Jvi.02274-15 |
0.581 |
|
2014 |
Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy. 58: 4885-93. PMID 24841273 DOI: 10.1128/Aac.03036-14 |
0.665 |
|
Show low-probability matches. |